Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis

Hal Broxmeyer, D. E. Williams, K. Geissler, G. Hangoc, S. Cooper, D. C. Bicknell, S. Levi, P. Arosio

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purified recombinant human heavy-chain (acidic) ferritin (rHF) was assessed in vivo in mice for effects on the proliferation (percentage of cells in S-phase) and absolute numbers of granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells in the femur and spleen and on the nucleated cells in the marrow, spleen, and blood. rHF significantly decreased cycling rates and absolute numbers of marrow and splenic hematopoietic progenitors and marrow and blood nucleated cellularity. These effects were apparent in BDF1, C3H/Hej and DBA/2 mice and were dose dependent, time related, and reversible. Suppressive effects were noted within three hours for progenitor cell cycling, within 24 hours for progenitor cell numbers, and within 48 hours for circulating neutrophils. Additionally, hematopoietic progenitor cells in DBA/2 mice infected with the polycythemia-inducing strain of the Friend virus complex (FVC-P) were insensitive to the in vivo administration of rHF. These studies demonstrate activity of rHR in vivo on myelopoiesis of normal but not FVC-P-infected mice. Since rHF suppresses hematopoietic progenitor cell proliferation from normal donors in vitro and from normal mice in vitro and in vivo but does not suppress progenitor cells from patients with leukemia in vitro or from mice with FVC-P-infection in vitro or in vivo, rHF may be useful as a candidate adjunct molecule for the protection of normal hematopoietic progenitor cells during chemotherapy.

Original languageEnglish
Pages (from-to)74-79
Number of pages6
JournalBlood
Volume73
Issue number1
StatePublished - 1989

Fingerprint

Myelopoiesis
Apoferritins
Friend murine leukemia virus
Ferritins
Viruses
Stem Cells
Hematopoietic Stem Cells
Inbred DBA Mouse
Bone Marrow
Blood
Chemotherapy
Spleen
Macrophages
Cell Proliferation
Cell proliferation
Myeloid Progenitor Cells
Polycythemia
Granulocyte-Macrophage Progenitor Cells
Erythroid Precursor Cells
Virus Diseases

ASJC Scopus subject areas

  • Hematology

Cite this

Broxmeyer, H., Williams, D. E., Geissler, K., Hangoc, G., Cooper, S., Bicknell, D. C., ... Arosio, P. (1989). Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. Blood, 73(1), 74-79.

Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. / Broxmeyer, Hal; Williams, D. E.; Geissler, K.; Hangoc, G.; Cooper, S.; Bicknell, D. C.; Levi, S.; Arosio, P.

In: Blood, Vol. 73, No. 1, 1989, p. 74-79.

Research output: Contribution to journalArticle

Broxmeyer, H, Williams, DE, Geissler, K, Hangoc, G, Cooper, S, Bicknell, DC, Levi, S & Arosio, P 1989, 'Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis', Blood, vol. 73, no. 1, pp. 74-79.
Broxmeyer H, Williams DE, Geissler K, Hangoc G, Cooper S, Bicknell DC et al. Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. Blood. 1989;73(1):74-79.
Broxmeyer, Hal ; Williams, D. E. ; Geissler, K. ; Hangoc, G. ; Cooper, S. ; Bicknell, D. C. ; Levi, S. ; Arosio, P. / Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. In: Blood. 1989 ; Vol. 73, No. 1. pp. 74-79.
@article{8577ce598e534003a398feab7b5d54c8,
title = "Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis",
abstract = "Purified recombinant human heavy-chain (acidic) ferritin (rHF) was assessed in vivo in mice for effects on the proliferation (percentage of cells in S-phase) and absolute numbers of granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells in the femur and spleen and on the nucleated cells in the marrow, spleen, and blood. rHF significantly decreased cycling rates and absolute numbers of marrow and splenic hematopoietic progenitors and marrow and blood nucleated cellularity. These effects were apparent in BDF1, C3H/Hej and DBA/2 mice and were dose dependent, time related, and reversible. Suppressive effects were noted within three hours for progenitor cell cycling, within 24 hours for progenitor cell numbers, and within 48 hours for circulating neutrophils. Additionally, hematopoietic progenitor cells in DBA/2 mice infected with the polycythemia-inducing strain of the Friend virus complex (FVC-P) were insensitive to the in vivo administration of rHF. These studies demonstrate activity of rHR in vivo on myelopoiesis of normal but not FVC-P-infected mice. Since rHF suppresses hematopoietic progenitor cell proliferation from normal donors in vitro and from normal mice in vitro and in vivo but does not suppress progenitor cells from patients with leukemia in vitro or from mice with FVC-P-infection in vitro or in vivo, rHF may be useful as a candidate adjunct molecule for the protection of normal hematopoietic progenitor cells during chemotherapy.",
author = "Hal Broxmeyer and Williams, {D. E.} and K. Geissler and G. Hangoc and S. Cooper and Bicknell, {D. C.} and S. Levi and P. Arosio",
year = "1989",
language = "English",
volume = "73",
pages = "74--79",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis

AU - Broxmeyer, Hal

AU - Williams, D. E.

AU - Geissler, K.

AU - Hangoc, G.

AU - Cooper, S.

AU - Bicknell, D. C.

AU - Levi, S.

AU - Arosio, P.

PY - 1989

Y1 - 1989

N2 - Purified recombinant human heavy-chain (acidic) ferritin (rHF) was assessed in vivo in mice for effects on the proliferation (percentage of cells in S-phase) and absolute numbers of granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells in the femur and spleen and on the nucleated cells in the marrow, spleen, and blood. rHF significantly decreased cycling rates and absolute numbers of marrow and splenic hematopoietic progenitors and marrow and blood nucleated cellularity. These effects were apparent in BDF1, C3H/Hej and DBA/2 mice and were dose dependent, time related, and reversible. Suppressive effects were noted within three hours for progenitor cell cycling, within 24 hours for progenitor cell numbers, and within 48 hours for circulating neutrophils. Additionally, hematopoietic progenitor cells in DBA/2 mice infected with the polycythemia-inducing strain of the Friend virus complex (FVC-P) were insensitive to the in vivo administration of rHF. These studies demonstrate activity of rHR in vivo on myelopoiesis of normal but not FVC-P-infected mice. Since rHF suppresses hematopoietic progenitor cell proliferation from normal donors in vitro and from normal mice in vitro and in vivo but does not suppress progenitor cells from patients with leukemia in vitro or from mice with FVC-P-infection in vitro or in vivo, rHF may be useful as a candidate adjunct molecule for the protection of normal hematopoietic progenitor cells during chemotherapy.

AB - Purified recombinant human heavy-chain (acidic) ferritin (rHF) was assessed in vivo in mice for effects on the proliferation (percentage of cells in S-phase) and absolute numbers of granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells in the femur and spleen and on the nucleated cells in the marrow, spleen, and blood. rHF significantly decreased cycling rates and absolute numbers of marrow and splenic hematopoietic progenitors and marrow and blood nucleated cellularity. These effects were apparent in BDF1, C3H/Hej and DBA/2 mice and were dose dependent, time related, and reversible. Suppressive effects were noted within three hours for progenitor cell cycling, within 24 hours for progenitor cell numbers, and within 48 hours for circulating neutrophils. Additionally, hematopoietic progenitor cells in DBA/2 mice infected with the polycythemia-inducing strain of the Friend virus complex (FVC-P) were insensitive to the in vivo administration of rHF. These studies demonstrate activity of rHR in vivo on myelopoiesis of normal but not FVC-P-infected mice. Since rHF suppresses hematopoietic progenitor cell proliferation from normal donors in vitro and from normal mice in vitro and in vivo but does not suppress progenitor cells from patients with leukemia in vitro or from mice with FVC-P-infection in vitro or in vivo, rHF may be useful as a candidate adjunct molecule for the protection of normal hematopoietic progenitor cells during chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0024496308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024496308&partnerID=8YFLogxK

M3 - Article

C2 - 2910370

AN - SCOPUS:0024496308

VL - 73

SP - 74

EP - 79

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -